Open AccessTapentadol treatment results in long-term pain relief in patients with chronic low back pain and associates with reduced segmental sensitization
Author(s) -
Tine van de Donk,
Jurjan van Cosburgh,
Tom van Dasselaar,
Monique van Velzen,
Asbjørn Mohr Drewes,
Albert Dahan,
Marieke Niesters
Publication year - 2020
Publication title -
pain reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.113
H-Index - 15
ISSN - 2471-2531
DOI - 10.1097/pr9.0000000000000877
Subject(s) - tapentadol , medicine , placebo , low back pain , anesthesia , chronic pain , nociception , analgesic , back pain , physical therapy , opioid , alternative medicine , receptor , pathology
The endogenous pain system may be used as a biomarker in the pharmacological treatment of patients with CLBP, enabling an individualized, mechanism-based treatment approach.